LivDerm Articles

LATEST Articles

Explore Articles

Selector filter
Sort Post

National Retinol Day

National Retinol Day is November 7. Retinol is one of the most popular anti-aging skincare ingredients on the market today.

A Closer Look at the Risks of Benzene in Skincare Products

Tune in to Dr. Christopher Bunick's SBS presentation as he discusses the risks posed by the human carcinogen, benzene.

November is National Healthy Skin Month

Here are some ways you can help educate your patients on the importance of maintaining healthy skin.

LiVDerm Launches New Exciting Webinars

LiVDerm is committed to providing relevant, industry-specific content for practitioners to enhance and grow their level of expertise. 

Study Finds Systemic Treatment of Atopic Dermatitis Relieves Skin Symptoms and Improves Depression

Study reveals that systemic treatment of atopic dermatitis can lead to an increase in relief of symptoms and improved mood.

World Psoriasis Day 2022

World Psoriasis Day is October 29th. This year's theme looks beyond the skin and addresses the mental health implications.

Topical Corticosteroids and Eczema: Insights from Dr. Peter Lio

Dr. Peter Lio provides insight into the use of topical corticosteroids in eczema.

Supporting Continued Dermatologic Education

Keeping on top of current trends, emerging therapies, and innovative technologies is vital to you and your practice.

The Millennial Aesthetic Patient

A brief look at how millennial patients are helping to shape the face of dermatologic aesthetic education.

Monkeypox Case Rates Higher In Black American Population

According to a recent Kaiser Family Foundation report, there are continued disparities in monkeypox cases among Black Americans.

A Recap of the MOPD Pediatric Skin of Color Virtual Summit

Read a recap of LiVDerm's recent Masters of Pediatric Dermatology Skin of Color Virtual Summit, presented by expert pediatric dermatologists.

Emerging Therapeutics in Atopic Dermatitis

An increase in atopic dermatitis research has led to an overall improved understanding of the condition.

New Study of Roflumilast Foam for Scalp and Body Psoriasis Shows Positive Results

Arcutis Biotherapeutics announces positive results of its pivotal phase three trial of roflumilast foam 0.3% for scalp and body psoriasis.

World Arthritis Day: Looking Beyond the Joints

Each year the world recognizes Arthritis Day to raise awareness about one of the most common disorders affecting millions worldwide.

National PA Week: Q&A with LiVDerm’s Expert Physician Assistants 

In honor of National Physician Assistant Week, LiVDerm caught up with PA's Jennifer Martinez, PA-C, and Gina McLean, PA-C.

FDA Approval of Dupilumab: Thoughts from Dr. Lal

The U.S. Food and Drug Administration recently approved dupilumab as the first and only treatment for adults with prurigo nodularis. 

LiVDerm: Who We Are

Here is a brief overview of LiVDerm that explains who we are, what we do, and what exactly we offer…

Atopic Dermatitis and Mental Health: Addressing More Than Just the Itch

Exploring the link between atopic dermatitis and mental health and looking towards a multidisciplinary approach to treatment.

The Five Pillars of Atopic Dermatitis

Atopic dermatitis can be a debilitating condition and a challenge to the patient and those tasked with caring for them.

October is National Eczema Awareness Month

Eczema affects approximately 30 million people in the U.S. of which Atopic Dermatitis is the most common form.


Sign up to receive updates on educational opportunities, complimentary content, exclusive discounts, and more.